You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR LANSOPRAZOLE; NAPROXEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LANSOPRAZOLE; NAPROXEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00175032 ↗ A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin Completed Takeda Phase 3 2003-07-01 The purpose of this study is to compare the gastroduodenal ulceration rate, gastrointestinal complication rate and non-steroidal anti-inflammatory drug-associated dyspepsia between lansoprazole, naproxen and celecoxib, taken once daily (QD) or twice daily (BID), in participants with osteoarthritis taking low dose aspirin.
NCT02017197 ↗ Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil Completed Fundação de Amparo à Pesquisa do Estado de São Paulo Phase 4 2014-08-01 The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks.
NCT02017197 ↗ Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil Completed Federal University of São Paulo Phase 4 2014-08-01 The purpose of this study is to assess whether the switch from branded to generic warfarin or between different generic warfarin tablets may cause fluctuation in the results of coagulation tests (International Normalized Rate, acronym INR) in patients, thus predisposing them to unnecessary risks.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LANSOPRAZOLE; NAPROXEN

Condition Name

Condition Name for LANSOPRAZOLE; NAPROXEN
Intervention Trials
Gout 2
Atrial Fibrillation 1
Moderate Renal Impairment 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LANSOPRAZOLE; NAPROXEN
Intervention Trials
Gout 2
Peptic Ulcer 1
Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LANSOPRAZOLE; NAPROXEN

Trials by Country

Trials by Country for LANSOPRAZOLE; NAPROXEN
Location Trials
United States 68
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LANSOPRAZOLE; NAPROXEN
Location Trials
Kentucky 2
South Carolina 2
Louisiana 2
Massachusetts 2
Michigan 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LANSOPRAZOLE; NAPROXEN

Clinical Trial Phase

Clinical Trial Phase for LANSOPRAZOLE; NAPROXEN
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LANSOPRAZOLE; NAPROXEN
Clinical Trial Phase Trials
Completed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LANSOPRAZOLE; NAPROXEN

Sponsor Name

Sponsor Name for LANSOPRAZOLE; NAPROXEN
Sponsor Trials
Takeda 3
Fundação de Amparo à Pesquisa do Estado de São Paulo 1
Federal University of São Paulo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LANSOPRAZOLE; NAPROXEN
Sponsor Trials
Industry 3
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.